MET · Metlife Inc · Documents

Apr 29

Proxy statement DEF 14A Meeting Jun 17, 2025

Proxy statement

Apr 29

Annual report to holders ARS

Annual report to holders

Apr 29

Proxy statement DEFA14A

Proxy statement

Mar 28

Current report 8-K Events of Mar 27

Director or officer change, or executive pay

Mar 13

Current report 8-K Events of Mar 11

New debt or off-balance-sheet obligation, Other events

Mar 5

Current report 8-K

Other events

Mar 4

Current report 8-K

New debt or off-balance-sheet obligation

Feb 27

Current report 8-K Events of Feb 25

Director or officer change, or executive pay

Feb 21

Annual report 10-K FY2024, ended Dec 31

Annual report for FY2024

Revenue $70.99B ▲ 6.1% Net income $4.43B ▲ 180.5% Diluted EPS $5.94 ▲ 228.2%

Feb 18

Current report 8-K

Other events

Feb 6

Earnings call

Q4 2024 earnings call

Feb 5

Current report 8-K

Financial results, Regulation FD disclosure, Other events

Jan 10

Current report 8-K Events of Jan 7

Director or officer change, or executive pay

Dec 12

Current report 8-K

Regulation FD disclosure

Dec 11

Current report 8-K

Regulation FD disclosure

Nov 15

Current report 8-K

Other events

Nov 1

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $18.44B ▲ 16.2% Net income $1.34B ▲ 174.4% Diluted EPS $1.81 ▲ 223.2%

Oct 31

Earnings call

Q3 2024 earnings call

Oct 30

Current report 8-K

Financial results, Regulation FD disclosure, Other events

Sep 30

Current report 8-K Events of Sep 26

New debt or off-balance-sheet obligation, Other events

Aug 15

Current report 8-K

Other events

Aug 1

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $17.82B ▲ 7.2% Net income $946M ▲ 135.3% Diluted EPS $1.28 ▲ 166.7%

Jul 31

Earnings call

Q2 2024 earnings call

Jul 31

Current report 8-K

Financial results, Regulation FD disclosure, Other events

Jun 24

Current report 8-K Events of Jun 18

Director or officer change, or executive pay, Shareholder vote results

Jun 5

Current report 8-K Events of Jun 3

New debt or off-balance-sheet obligation, Other events

May 15

Current report 8-K

Other events

May 2

Earnings call

Q1 2024 earnings call

May 2

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $16.06B ▲ 4.3% Net income $867M ▲ 983.8% Diluted EPS $1.10 ▲ 5400.0%

May 1

Current report 8-K

Financial results, Regulation FD disclosure, Other events

Apr 26

Proxy statement DEF 14A Meeting Jun 18, 2024

Proxy statement

Apr 26

Annual report to holders ARS

Annual report to holders

Apr 26

Proxy statement DEFA14A

Proxy statement

Mar 12

Current report 8-K

Other events

Mar 7

Current report 8-K Events of Mar 1

New debt or off-balance-sheet obligation, Other events

Mar 5

Current report 8-K

Other events

Feb 28

Current report 8-K Events of Feb 27

Director or officer change, or executive pay

Feb 16

Annual report 10-K Ended Dec 31

Annual report for the period ended Dec 31, 2023

Revenue $66.91B ▼ 2.7% Net income $1.58B ▼ 70.1% Diluted EPS $1.81 ▼ 71.3%

Feb 15

Current report 8-K

Other events

Feb 1

Earnings call

Q4 2023 earnings call

Jan 31

Current report 8-K

Financial results, Regulation FD disclosure, Other events

Nov 16

Current report 8-K

Regulation FD disclosure, Other events

Nov 15

Current report 8-K

Other events

Nov 2

Earnings call

Q3 2023 earnings call

Nov 2

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $15.87B ▼ 28.8% Net income $489M ▼ 57.9% Diluted EPS $0.56 ▼ 59.1%

Nov 1

Current report 8-K

Financial results, Regulation FD disclosure, Other events

Oct 5

Current report 8-K/A Events of Jun 20

Shareholder vote results

Oct 5

Current report 8-K Events of Oct 3

Charter or bylaw amendment, or fiscal year change

Aug 15

Current report 8-K

Other events

Aug 4

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $16.62B ▲ 7.4% Net income $402M ▼ 55.8% Diluted EPS $0.48 ▼ 55.6%